| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/11/2006 | US7074560 Purification of tissue plasminogen activator (tPA) |
| 07/11/2006 | CA2440583C A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 07/11/2006 | CA2109433C Substituted benzhydrylamines as handles for solid phase peptide synthesis |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/06/2006 | WO2006072048A2 Compositions and methods for identifying modulators of hausp |
| 07/06/2006 | WO2006069718A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 07/06/2006 | US20060149034 Homing peptides to receptors of heart vasculature |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060149032 Recombinant hepatitis B surface antigen |
| 07/06/2006 | US20060148718 complex of cytotoxic agent to polypeptides; amino acid sequence proteolytic splitting protate specific antigen; therapy for protate cancer and benign prostate hyperplasia |
| 07/06/2006 | US20060148717 Biocidal proteins |
| 07/06/2006 | US20060148716 Octapeptides: Arg-X-Asp-Leu-Asp-Ser-Leu-Arg where X is a 2-aminoaulfonylaminoalkanoic acid and optionally having various end groups; biologically active as ligands of blood platelet integrin GPIIbIIIa and the alpha v integrins |
| 07/06/2006 | US20060148711 Molecular interactions in neurons |
| 07/06/2006 | US20060148710 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants |
| 07/06/2006 | US20060148679 Glycosolated enkephalin agents |
| 07/06/2006 | US20060148101 Fluorescent ligands for GPCR arrays |
| 07/06/2006 | US20060148060 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 07/06/2006 | US20060148055 Oxidised fragments of apolioprotein B and their uses |
| 07/06/2006 | US20060147914 evaluating ability of agents to modulate Homer protein activity, Homer protein/immunophilin-peptidylproline cis-trans isomerase interaction, and/or Homer protein/proline-type Homer ligand consensus sequence interaction to identify agents for treatment; modulation of immunosupression and neuroprotection |
| 07/06/2006 | US20060144876 Lock for a flat and low pourer with a removable element in the form of a laminate of film for a composite package for container openings closed by nonpermeable film |
| 07/06/2006 | CA2593086A1 Anti-tumoral immunogenic peptides and vaccine thereof |
| 07/06/2006 | CA2592690A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 07/05/2006 | EP1676859A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 07/05/2006 | EP1676856A1 Peptide originating in hepatitis c virus |
| 07/05/2006 | EP1676588A1 Polyarginine-modified liposome capable of transferring into nucleus |
| 07/05/2006 | EP1675606A2 Peptides and compounds that bind to thrombopoietin receptors |
| 07/05/2006 | EP1210373B1 Congener independent detection of microcystin and nodularin congeners |
| 07/05/2006 | EP1112496B1 Diagnostic method for detecting disturbances of the pancreas |
| 07/05/2006 | CN1798759A Process for preparation of cyclosporin 'a' analogues having a terminal diene group |
| 07/05/2006 | CN1262651C Method for giving resistance to weed control compounds to plants |
| 07/05/2006 | CN1262563C Neutral and variable sites of cytomembrane protein M2 of influenza virus and their use |
| 07/05/2006 | CN1262562C HLA-A2 restraint tumor antigen peptide originating in SART-1 |
| 07/05/2006 | CN1262561C Synthetic poly peptide disturbing intracelluler signaling |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071299 For therapy of conditions characterized by inappropriate complement activation; for therapy of adult respiratory distress syndrome, ischemia-reperfusion injury, hyperacute rejection (transplantation), sepsis, cardiopulmonary bypass |
| 07/04/2006 | US7071293 Protein; biological antigrowth agent; bactericides |
| 07/04/2006 | US7071168 To inhibit tumor growth in an animal; to induce apoptosis |
| 07/04/2006 | US7071167 Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines |
| 07/04/2006 | US7071165 LHRH antagonist peptides |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | US7070921 Monitoring enzymatic activity; incubate substrate and binding particles, incubate substrate and enzyme, detect and evaluate enzymatic response |
| 07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
| 07/04/2006 | US7070782 Prostate-specific membrane antigen |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 06/29/2006 | WO2006068640A1 Protein phosphorylation in egfr-signaling pathways |
| 06/29/2006 | WO2006068250A1 Nanographite structure/metal nanoparticle composite |
| 06/29/2006 | WO2006067091A1 Myd88 homodimerization inhibitors |
| 06/29/2006 | WO2005087793A3 Immunostimulatory compositions and uses thereof |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142201 amino acid sequence containing Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; prophylaxis; neuropathic pain, inflammation, incontinence, cardiovascular conditions |
| 06/29/2006 | US20060140858 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/29/2006 | DE10335584B4 Verfahren zur Herstellung zyklischer Moleküle A process for preparing cyclic molecules |
| 06/29/2006 | CA2817636A1 Radiolabelled conjugates of rgd-containing peptides and methods for their preparation via click-chemistry |
| 06/29/2006 | CA2601700A1 Protein phosphorylation in egfr-signaling pathways |
| 06/29/2006 | CA2594053A1 Vacuole targeting peptide and nucleic acid |
| 06/29/2006 | CA2590750A1 Myd88 homodimerization inhibitors |
| 06/28/2006 | EP1674477A2 Binding polypeptides for B lymphocyte stimulator protein (BLYS) |
| 06/28/2006 | EP1673633A1 Method and device for detecting feline immunodeficiency virus |
| 06/28/2006 | EP1673101A1 Lim2 inhibitors of lmo2 |
| 06/28/2006 | EP1224290B1 Disulfide conjugated cell toxins and methods of making and using them |
| 06/28/2006 | EP0772774B1 Determination of a specific immunoglobulin using multiple antigens |
| 06/28/2006 | CN1795386A Diagnosis of autism |
| 06/28/2006 | CN1795007A Methods and compositions for the treatment of gastrointestinal disorders |
| 06/28/2006 | CN1793169A Sea snail toxin variant polypeptide compound, its preparation process and application thereof |
| 06/27/2006 | US7067698 Preparation of preferential oligomers for use as therapeutic tools; obtain oligomer, incubate with amines, expose to guanidinylation reagent, recover oligomer |
| 06/27/2006 | US7067624 Antimicrobial proteins |
| 06/27/2006 | US7067623 Support (silica, glass beads) is reacted to form volatile compound which is separated from cleaved product (peptide) by vaporization in one step; eliminates filtering and extraction |
| 06/27/2006 | US7067619 Integrin-binding peptides |
| 06/27/2006 | US7067490 Hepta-, Octa-and nonapeptides having antiangiogenic activity |
| 06/27/2006 | US7067482 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/27/2006 | US7067326 Binding particle for use in the biosynthesis and separation of particles in sample |
| 06/27/2006 | US7067273 Comprises amino acid sequences which serve as substrates for a disintegrin and metalloprotease (ADAM) for use in identification of modulator for treatment of asthma |
| 06/27/2006 | US7067136 Proteins; gene expression of antigen in vivo; genetic engineering; detection of antibiotics ; drug design; plasmids |
| 06/27/2006 | US7067112 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline |
| 06/22/2006 | WO2006064530A2 Dermorphin analogs with analgesic activity |
| 06/22/2006 | WO2006063783A1 Method for the deacylation of lipopeptides |
| 06/22/2006 | WO2006063723A2 High-throughput enzyme-linked immuno absorbent assay (ht-elisa) for identifying r rho-kinase (rok) modulator |
| 06/22/2006 | WO2006063470A1 Metabolites of cyclosporin analogs |
| 06/22/2006 | WO2006039164A3 Novel cyclosporin analogues and their pharmaceutical uses |
| 06/22/2006 | WO2005105832A3 Biologically active peptide vapeehptllteaplnpk derivatives |
| 06/22/2006 | WO2005087731A8 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/22/2006 | WO2005010030A3 C5a receptor antagonists |
| 06/22/2006 | US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 06/22/2006 | US20060135436 Peptides and methods for the control of obesity |
| 06/22/2006 | US20060135434 New peptides |
| 06/22/2006 | US20060135433 Phenolic binding peptides |
| 06/22/2006 | US20060135432 Peptide antagonists of GnRH-2 that bind to GnRH-2 receptors; useful for the treatment of reproductive diseases and steroid-related cancers |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135430 BLy antagonists and uses thereof |
| 06/22/2006 | US20060135428 kringle peptides; peptidase stabilized |
| 06/22/2006 | US20060135414 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 06/22/2006 | US20060135410 Targeted delivery to legumain-expressing cells |
| 06/22/2006 | US20060135408 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 06/22/2006 | US20060134126 Peptide constructs for treating disease |
| 06/22/2006 | CA2592343A1 Metabolites of cyclosporin analogs |
| 06/22/2006 | CA2590499A1 High-throughput enzyme-linked immuno absorbent assay (elisa) for determination of rho-kinase (rok) activity |
| 06/21/2006 | EP1670899A2 Vaccines for cancer, autoimmune disease and infections |
| 06/21/2006 | EP1670816A2 Fluorescence assay for kinase activity |
| 06/21/2006 | EP1670815A2 Melanocortin receptor agonists |
| 06/21/2006 | EP1670434A1 Methods for preparing oil bodies comprising active ingredients |